Recent Advances in Thrombosis and Hemostasis—Part V

Sam Schulman

doi:10.1055/s-0039-1700490

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2019; 45(08): 757-759
DOI: 10.1055/s-0039-1700490

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Recent Advances in Thrombosis and Hemostasis—Part V

Sam Schulman

¹Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada

²Department of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University, Moscow, Russia

References
1 Ohbe H, Isogai S, Jo T, Matsui H, Fushimi K, Yasunaga H. Treatment with antithrombin or thrombomodulin and mortality from heatstroke-induced disseminated intravascular coagulation: a nationwide observational study. Semin Thromb Hemost 2019; 45 (08) 760-766
2 Yang L, Qi J, Pan T, You T, Ruan C, Han Y. Efficacy and safety of defibrotide for the treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis. Semin Thromb Hemost 2019; 45 (08) 767-777
3 Marongiu F, Mameli A, Grandone E, Barcellona D. Pulmonary thrombosis: a clinical pathologic entity distinct from pulmonary embolism?. Semin Thromb Hemost 2019; 45 (08) 778-783
4 Lippi G, Favaloro EJ, Kavsak P. Measurement of high-sensitivity cardiac troponin in pulmonary embolism: useful test or a clinical distraction?. Semin Thromb Hemost 2019; 45 (08) 784-792
5 Bikdeli B, Jiménez D, Garcia-Tsao G. , et al. Venous thromboembolism in patients with liver cirrhosis: findings from the RIETE registry. Semin Thromb Hemost 2019; 45 (08) 793-801
6 Stevens H, McFadyen JD. Platelets as central actors in thrombosis - reprising an old role and defining a new character. Semin Thromb Hemost 2019; 45 (08) 802-809
7 Eck RJ, Bult W, Wetterslev J. , et al. Intermediate dose low-molecular-weight heparin for thrombosis prophylaxis: systematic review with meta-analysis and trial sequential analysis. Semin Thromb Hemost 2019; 45 (08) 802-809
8 Orsi FA, Cannegieter SC, Lijfering WM. Statin therapy to revert hypercoagulability and prevent venous thromboembolism: a narrative review. Semin Thromb Hemost 2019; 45 (08) 825-833
9 Lippi G, Favaloro EJ. Statins for preventing venous thrombosis: for or against?. Semin Thromb Hemost 2019; 45 (08) 834-836
10 Jiménez-Serranía M-I, Lobato CT. Influence of concomitant treatments under anticoagulants and statins in detecting signals of adverse drug reactions. Semin Thromb Hemost 2019; 45 (08) 837-845
11 Bolek T, Samoš M, Škorňová I. , et al. Proton pump inhibitors and dabigatran therapy: impact on gastric bleeding and dabigatran plasma levels. Semin Thromb Hemost 2019; 45 (08) 846-850
12 Spirk D, Sebastian T, Banyai M. , et al. Venous thromboembolism and renal impairment: insights from the SWIss Venous ThromboEmbolism Registry (SWIVTER). Semin Thromb Hemost 2019; 45 (08) 851-858
13 Arachchillage DRJ, Gaspar M, Makhecha S, Laffan M. Use of antithrombin concentrate for acquired antithrombin deficiency in acutely unwell children receiving unfractionated heparin. Semin Thromb Hemost 2019; 45 (08) 859-864